Open Access

[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway

  • Authors:
    • Dongjie Ma
    • Shanqing Li
    • Yushang Cui
    • Li Li
    • Hongsheng Liu
    • Yeye Chen
    • Xiaoyun Zhou
  • View Affiliations

  • Published online on: January 21, 2021     https://doi.org/10.3892/ol.2021.12480
  • Article Number: 219
  • Copyright : © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

March-2021
Volume 21 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ma D, Li S, Cui Y, Li L, Liu H, Chen Y and Zhou X: [Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. Oncol Lett 21: 219, 2021.
APA
Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., & Zhou, X. (2021). [Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. Oncology Letters, 21, 219. https://doi.org/10.3892/ol.2021.12480
MLA
Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., Zhou, X."[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway". Oncology Letters 21.3 (2021): 219.
Chicago
Ma, D., Li, S., Cui, Y., Li, L., Liu, H., Chen, Y., Zhou, X."[Retracted] Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway". Oncology Letters 21, no. 3 (2021): 219. https://doi.org/10.3892/ol.2021.12480